
    
      To investigate the safety and tolerability of escalating single doses of CAM-3001 in patients
      with RA; To investigate the pharmacokinetics of single doses of CAM-3001 in RA patients; To
      investigate the pharmacodynamics of single doses of CAM-3001 in RA patients; To investigate
      the preliminary clinical effects of CAM-3001 on the signs and symptoms of RA.
    
  